Pith. sign in

REVIEW 3 major objections 3 minor 1 cited by

This paper argues that diversity in the initial retrieval of in-context demonstrations—not ranking-stage optimization—is the dominant factor for biomedical few-shot LLM performance, and that a two-stage submodular selector achieves up to 5%

Reviewed by Pith at T0; open to challenge. T0 means a machine referee read the full paper against a public rubric. the ladder, T0–T4 →

A diversity-first, submodular two-stage demonstration selector beats representative-only baselines for biomedical in-context learning, with 3 to 5 examples optimal.

T0 review reviewed 2026-08-05 challenge →

load-bearing objection A plausible and potentially useful method paper whose central empirical claims are unverified from the abstract alone; the stage-1 coverage worry is real and should be addressed in full-text review. the 3 major comments →

arxiv 2508.08140 v1 pith:MJ2RJBY5 submitted 2025-08-11 cs.CL

Data-Efficient Biomedical In-Context Learning: A Diversity-Enhanced Submodular Perspective

classification cs.CL
keywords in-context learningdemonstration selectionsubmodular optimizationdiversitybiomedical NLPfew-shot learninglarge language modelsmacro-F1
verification ladder T0 review T1 audit T2 compute T3 formal T4 reserved

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper tries to establish how demonstrations are chosen from a corpus matters more than which ranking is applied at the end, and that the winning strategy is to make the first pass explicitly diverse. Concretely, the authors propose Dual-Div, a two-stage selector that first builds a candidate pool by optimizing both representativeness and diversity—optionally using annotation to cover unlabeled data—then ranks those candidates against the test query to pick the most relevant, non-redundant few shots. They report that on biomedical named entity recognition, relation extraction, and text classification, across two LLMs and three retrievers, this beats representativeness-only baselines by up to 5 macro-F1 points, is stable under prompt permutations and class imbalance, and that 3–5 examples is the efficiency optimum. A sympathetic reader would care because few-shot in-context learning is the main way LLMs adapt to specialized biomedical tasks without fine-tuning, so a cheap, data-efficient selection rule that reliably adds points matters for practical use.

Core claim

On the paper's own terms, the central claim is that a diversity-enhanced submodular objective at the candidate-retrieval stage dominates downstream ranking optimization in demonstration selection for biomedical in-context learning. Dual-Div's stage one chooses a small candidate set from the corpus by jointly maximizing representativeness and diversity (with the option of annotation to handle unlabeled data); stage two then ranks only those candidates against each test query. The reported result is that this pipeline outperforms baselines that emphasize representativeness at both stages, with up to 5% higher macro-F1, and that resistance to prompt permutations and class imbalance follows from

What carries the argument

The central object is the submodular objective in Dual-Div's two-stage pipeline. In stage one, a submodular function combines representativeness (coverage of the corpus) with diversity (penalizing redundancy among selected examples), yielding a limited candidate pool; optionally, annotation is used to incorporate unlabeled data. In stage two, those candidates are ranked against the test query to pick the most relevant and non-redundant few-shot demonstrations. The claim that diversity at initial retrieval outweighs ranking-stage optimization is carried by the comparison between this two-stage design and representativeness-only baselines.

Load-bearing premise

The approach assumes that the stage-one candidate pool, built from corpus-wide representativeness and diversity before seeing any test query, always contains the most informative example for that query—if a useful demonstration is pruned in stage one, the stage-two ranker can never recover it.

What would settle it

Take a small biomedical corpus and, for a fixed test query, compute the best possible demonstration by exhaustive search over all corpus examples. If in a substantial fraction of queries the best example lies outside the Dual-Div stage-one candidate set, or if replacing Dual-Div's stage-one pool with random sampling of equal size yields comparable macro-F1, then the claim that diversity in initial retrieval is the critical factor is falsified.

Watch this falsifier. Get emailed when new claim-graph text bears on it.

If this is right

  • If Dual-Div is correct, demonstration selection for biomedical ICL can be improved without extra inference cost, purely by changing how prompt examples are chosen.
  • The finding that 3–5 demonstrations are optimal gives a practical heuristic: adding more examples beyond that range is unlikely to help and may hurt.
  • The stage-one-dominance claim implies that retrieval-stage diversity should be a default consideration in ICL pipelines, not an afterthought in ranking.
  • Stability under prompt permutations and class imbalance, if true, makes Dual-Div a safer choice in low-resource biomedical settings where label distributions are skewed.
  • The optional annotation step for unlabeled corpora suggests a route to using large raw text collections without full labels.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • A testable extension would be to measure whether the same diversity-first ordering holds for general-domain ICL, not just biomedical text, since the paper's mechanism is task-agnostic.
  • The coverage assumption implies a concrete failure mode: on a query whose ideal example is pruned early, no stage-two reranking can restore it. Probing with adversarial queries would reveal how often that happens.
  • The 3–5 example optimum may depend on the evaluated LLMs and retrievers; the paper does not control for model scale, so larger models could shift the optimum.
  • The 'diversity is more critical' claim is comparative, not absolute; it does not mean representativeness is useless, only that at the retrieval stage it matters less. A follow-up could test whether the two stages can be reordered or merged without loss.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit.

Referee Report

3 major / 3 minor

Summary. The paper proposes Dual-Div, a two-stage demonstration-selection method for in-context learning on biomedical NLP tasks. Stage 1 builds a limited candidate set from a corpus by optimizing both representativeness and diversity via submodular functions; stage 2 ranks these candidates against a test query to pick relevant, non-redundant demonstrations. The authors evaluate on three biomedical tasks (NER, RE, TC) with two LLMs (LLaMA 3.1, Qwen 2.5) and three retrievers (BGE-Large, BMRetriever, MedCPT), reporting up to 5% higher macro-F1 than baselines, robustness to prompt permutations and class imbalance, and two findings: diversity in initial retrieval is more critical than ranking-stage optimization, and 3-5 demonstrations maximize performance efficiency.

Significance. If the claims hold, the paper makes a practical contribution by showing that diversity-aware candidate selection improves few-shot biomedical ICL, an area where representativeness-only selection is common. The evaluation grid—three tasks, two LLMs, three retrievers, plus robustness checks on prompt permutations and class imbalance—is broader than is typical in the demonstration-selection literature. The two-stage formulation is also sensible for scaling to large corpora. However, the abstract-level evidence does not establish the central explanatory claim that diversity at stage 1 is more critical than ranking at stage 2, because the stage-1 coverage assumption is not directly tested. The reported performance gains also lack statistical quantification. These are load-bearing gaps that need to be addressed before the findings can be accepted as stated.

major comments (3)
  1. [Abstract (two-stage process)] The central claim that 'diversity in initial retrieval is more critical than ranking-stage optimization' is underdetermined by the architecture. Stage 2 ranks only candidates selected in stage 1, which is built from corpus statistics before the test query is seen. If the stage-1 pool omits the most informative example for a given query, stage 2 cannot recover it. Without an oracle-recall analysis (does the stage-1 pool contain the best demonstrations?) or an ablation over candidate-pool size, including a full-corpus ranker as an upper bound, the observed superiority of stage-1 diversity over stage-2 ranking could be an artifact of a bottlenecked candidate set rather than a property of the selector. This is a structural risk directly tied to the paper's headline finding.
  2. [Abstract (performance claims)] The abstract reports 'up to 5% higher macro-F1 scores' with no variance, confidence intervals, or significance tests. 'Consistently outperforms' and 'robustness to prompt permutations and class imbalance' are strong claims; without error bars or paired statistical tests across seeds, tasks, and models, the reader cannot assess whether the improvements are reliable or within noise. This is especially important for the downstream claim that 3-5 demonstrations are optimal, which requires comparing adjacent values of k.
  3. [Abstract (finding on demonstration count)] The statement that 'limiting demonstrations to 3-5 examples maximizes performance efficiency' appears to be a grid-search result. The abstract does not indicate whether this holds consistently across all task/model/retriever combinations, or whether differences between, say, 3 and 5 demonstrations are statistically meaningful. If the full paper includes per-cell results and significance testing, this comment is addressable in revision; as presented, the claim overspecifies the evidence.
minor comments (3)
  1. [Abstract] The phrase 'with optional annotation for unlabeled data' is vague. Does this mean the method can incorporate labeled or unlabeled data depending on availability, or that it has an annotation suggestion mode? Please define this in the abstract or introduction.
  2. [Abstract] The paper is about submodular optimization, but the abstract does not name the submodular function used or how representativeness and diversity are balanced. A sentence with the specific objective (e.g., facility location, graph cut) would help readers identify the contribution.
  3. [General] Because this is an abstract-only review, I could not verify whether the full text contains the ablations suggested above. If they are present, the abstract should be revised to summarize them; if not, they must be added.

Circularity Check

0 steps flagged

No circularity evident in the abstract-only review; claims are empirical and measured against external baselines.

full rationale

The paper is an empirical method-and-evaluation study. The abstract describes a two-stage retrieval-and-ranking framework (Dual-Div) and reports measured macro-F1 improvements over baselines on three biomedical NLP tasks. There is no derivation chain in which a prediction reduces by construction to a fitted parameter or a self-citation. The claim that 'diversity in initial retrieval is more critical than ranking-stage optimization' and the '3-5 examples optimal' finding are empirical outcomes of experiments, not consequences of how the method is defined. No equations are provided in the abstract, so there is no way to exhibit a specific reduction. The skeptic's concern about the stage-1 candidate pool bottleneck is a potential validity threat (coverage assumption), but it is not circularity: the candidate pool is not defined in terms of the final prediction, and the finding could in principle be false. The 'up to 5%' figure is a best-case performance claim, not a fitted value renamed as a prediction. There is also no evidence of self-citation serving as load-bearing justification. Therefore, no circularity can be identified from the available text.

Axiom & Free-Parameter Ledger

3 free parameters · 4 axioms · 0 invented entities

The framework's claims rest on three kinds of input: tunable hyperparameters (demo count, pool size, balance weight), modeling assumptions (submodularity, embedding quality, stage-1 coverage), and prior resources (LLMs and retrievers). The heaviest burden is the coverage assumption. No invented entities: Dual-Div composes existing components and posits no new particles, forces, or data structures beyond the framework itself.

free parameters (3)
  • number of demonstrations k = 3 to 5
    The abstract states that limiting demonstrations to 3-5 examples maximizes performance efficiency; this is an empirically selected range, not derived from theory.
  • stage-1 candidate pool size
    The abstract says stage 1 selects 'a limited set of candidate examples' without giving the size; this is a tunable hyperparameter that controls the coverage vs. cost trade-off and directly conditions stage-two results.
  • diversity-representativeness balance weight
    Stage 1 optimizes both representativeness and diversity, which requires a scalar weight or constraint bound in the submodular objective; the value is not reported in the abstract.
axioms (4)
  • domain assumption The selected utility function over demonstration sets is submodular (diminishing returns), so submodular maximization or its surrogate applies.
    Stated in the title and abstract as the 'submodular perspective'; it is a modeling choice about the selection objective, adopted to make greedy selection tractable, not a property proven for ICL utility.
  • domain assumption Retriever embeddings (BGE-Large, BMRetriever, MedCPT) are a faithful similarity space for defining both representativeness and diversity in biomedical text.
    The whole pipeline operates on the retrievers' vector spaces; if embeddings do not capture task-relevant structure, the diversity signal is noise. No analysis of embedding quality is visible in the abstract.
  • ad hoc to paper The stage-1 candidate pool, built without the test query, contains the demonstrations that the stage-2 ranker would need (coverage assumption).
    This is the load-bearing premise of the two-stage design identified as the weakest assumption: pruning to a query-independent candidate set caps the best achievable result before ranking begins.
  • domain assumption LLMs (LLaMA 3.1, Qwen 2.5) exhibit stable in-context learning on the three biomedical tasks, so performance differences are attributable to demonstration selection rather than model instability.
    The paper's robustness-to-prompt-permutation check addresses part of this, but the abstract gives no variance across seeds or runs.

reviewed 2026-08-05 · how reviews work

0 comments
Cite this review

Pith. "Pith review of Data-Efficient Biomedical In-Context Learning: A Diversity-Enhanced Submodular Perspective." pith.science (2026). https://pith.science/paper/MJ2RJBY5

@misc{pith2026250808140,
  author       = {Pith},
  title        = {Pith review of: Data-Efficient Biomedical In-Context Learning: A Diversity-Enhanced Submodular Perspective},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/MJ2RJBY5}},
  note         = {Machine review of arXiv:2508.08140}
}
Share X Bluesky LinkedIn Reddit HN
read the original abstract

Recent progress in large language models (LLMs) has leveraged their in-context learning (ICL) abilities to enable quick adaptation to unseen biomedical NLP tasks. By incorporating only a few input-output examples into prompts, LLMs can rapidly perform these new tasks. While the impact of these demonstrations on LLM performance has been extensively studied, most existing approaches prioritize representativeness over diversity when selecting examples from large corpora. To address this gap, we propose Dual-Div, a diversity-enhanced data-efficient framework for demonstration selection in biomedical ICL. Dual-Div employs a two-stage retrieval and ranking process: First, it identifies a limited set of candidate examples from a corpus by optimizing both representativeness and diversity (with optional annotation for unlabeled data). Second, it ranks these candidates against test queries to select the most relevant and non-redundant demonstrations. Evaluated on three biomedical NLP tasks (named entity recognition (NER), relation extraction (RE), and text classification (TC)) using LLaMA 3.1 and Qwen 2.5 for inference, along with three retrievers (BGE-Large, BMRetriever, MedCPT), Dual-Div consistently outperforms baselines-achieving up to 5% higher macro-F1 scores-while demonstrating robustness to prompt permutations and class imbalance. Our findings establish that diversity in initial retrieval is more critical than ranking-stage optimization, and limiting demonstrations to 3-5 examples maximizes performance efficiency.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. Quantized Large Language Models in Biomedical Natural Language Processing: Evaluation and Recommendation

    cs.CL 2025-09 conditional novelty 5.0

    Quantizing LLMs to 4 or 8 bits cuts GPU memory by up to 75% with generally small performance changes across eight biomedical NLP benchmarks.

This paper was first reviewed by deepseek-v4-flash on August 5, 2026.